CBX8 and neoplasm: Therefore, CBX8, c-Myc and cyclin A2 are most likely not good therapeutic targets; however, they are able to promote proliferation even while their inhibition may enhance metastasis, indicating that current strategies mainly targeting proliferation may have undesirable effects on tumor progression.